Goat Anti-ERBB2 / HER2 Antibody

Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.

100 µg

Aliquot and store at -20°C. Minimize freezing and thawing.

v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)|v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)|tyrosine kinase-type cell surface receptor HER2|TKR1|receptor tyrosine-protein kinase erbB-2|proto-oncogene Neu|proto-oncogene c-ErbB-2|p185erbB2|NGL|neuroblastoma/glioblastoma derived oncogene homolog|NEU|MLN 19|metastatic lymph node gene 19 protein|herstatin|HER-2/neu|HER-2|HER2|ERBB2|c-erb B2/neu protein|CD340

Immunofluorescence: Strong expression of the protein seen in U2OS cells. Recommended concentration: 10µg/ml.

Flow Cytometry: Flow cytometric analysis of U2OS cells. Recommended concentration: 10ug/ml.</p

NP_004439.2; NP_001005862.1; NP_001276867.1; NP_001276866.1; NP_001369713.1; NP_001369733.1

EBP11748

Peptide with sequence PREYVNARHCLP, from the internal region of the protein sequence according to NP_004439.2; NP_001005862.1; NP_001276867.1; NP_001276866.1; NP_001369713.1; NP_001369733.1.

This antibody is expected to recognise multiple isoforms.The immunizing peptide represents part of the extracellular domain.

PREYVNARHCLP

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Refrigerated

Human

Human

2064

In paraffin embedded Human breast cancer shows cell membrane and cytoplasm staining in the affected cells of Her+ type and not in triple negative type. Recommended concentration: 4-6µg/ml.

Antibody detection limit dilution 1:128000.

Pep-ELISA, IHC, IF, FC